Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms
A new narrative review finds that GLP-1 receptor agonists promote weight loss in patients with inflammatory bowel disease, with safety ...
